scispace - formally typeset
Open AccessJournal ArticleDOI

Serum anti‐Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3

TLDR
Serum AMH levels were more robustly correlated with the number of early antral follicles than inhibin B, E(2), FSH and LH on cycle day 3, suggesting that AMH may reflect ovarian follicular status better than the usual hormone markers.

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Ovarian Aging: Mechanisms and Clinical Consequences

TL;DR: Improved knowledge of the ovarian ageing mechanisms may ultimately provide tools for prediction of menopause and manipulation of the early steps of folliculogenesis for the purpose of contraception and fertility lifespan extension.
Journal ArticleDOI

Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)

TL;DR: AMH seems to be a better marker in predicting ovarian response to controlled ovarian stimulation than age of the patient, FSH, estradiol and inhibin B, and a similar performance for AMH and antral follicular count has been reported.
Journal ArticleDOI

Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy

TL;DR: Premenopausal women who undergo high-dose chemotherapy have a very high risk of ovarian failure and cryopreservation of ovarian tissue with subsequent autotransplantation has effectively preserved fertility in an animal model but its efficacy in humans has been uncertain.
Journal ArticleDOI

Anti-Müllerian hormone: a new marker for ovarian function

TL;DR: This review summarizes recent findings concerning AMH and its role as a marker for the quantitative aspect of ovarian reserve as well as ovarian dysfunction.
References
More filters
Journal ArticleDOI

Measurement of dimeric inhibin B throughout the human menstrual cycle.

TL;DR: Using this immunoassay, it was found that the plasma concentration of inhibin B rose rapidly in the early follicular phase to a peak of 85.2 +/- 9.6 pg/mL on the day after the intercycle FSH rise, then fell progressively during the remainder of the follicular phases, which suggests that these forms may have different physiological roles.
Journal ArticleDOI

Antimüllerian hormone serum levels: a putative marker for ovarian aging.

TL;DR: Serum concentrations of antimüllerian hormone decreased over time in young normo-ovulatory women, whereas other markers associated with ovarian aging did not change, and concentration correlate with the number of antral follicles and age and less strongly with FSH level.
Journal ArticleDOI

Anti-Müllerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary

TL;DR: It is suggested that AMH inhibits initia- tion of primordial follicle growth and therefore functions as an inhibitory growth factor in the ovary during these early stages of folliculogenesis.
Journal ArticleDOI

Anti-Müllerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary

TL;DR: It was shown that FSH-stimulated preantral follicle growth is attenuated in the presence of AMH, and in immature AMH-deficient females, more follicles start to grow under the influence of exogenous FSH than in their wild-type littermates.
Journal ArticleDOI

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles.

TL;DR: Data demonstrate an association between early follicular phase serum MIS and the number of retrieved oocytes in women undergoing ovulation induction in preparation for assisted reproductive technology (ART).
Related Papers (5)